首页> 美国卫生研究院文献>Allergy Asthma and Clinical Immunology : Official Journal of the Canadian Society of Allergy and Clinical Immunology >A four-way double-blind randomized placebo controlled study to determine the efficacy and speed of azelastine nasal spray versus loratadine and cetirizine in adult subjects with allergen-induced seasonal allergic rhinitis
【2h】

A four-way double-blind randomized placebo controlled study to determine the efficacy and speed of azelastine nasal spray versus loratadine and cetirizine in adult subjects with allergen-induced seasonal allergic rhinitis

机译:一项四路双盲随机安慰剂对照研究用于确定在过敏原诱发的季节性变应性鼻炎成年受试者中氮卓斯汀鼻喷雾剂氯雷他定和西替利嗪的疗效和速度

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundAzelastine has been shown to be effective against seasonal allergic rhinitis (SAR). The Environmental Exposure Unit (EEU) is a validated model of experimental SAR. The objective of this double-blind, four-way crossover study was to evaluate the onset of action of azelastine nasal spray, versus the oral antihistamines loratadine 10 mg and cetirizine 10 mg in the relief of the symptoms of SAR.
机译:背景已证明氮卓斯汀对季节性过敏性鼻炎(SAR)有效。环境暴露单位(EEU)是经过验证的实验性SAR模型。这项双盲,四向交叉研究的目的是评估氮卓斯汀鼻喷雾剂与口服抗组胺药氯雷他定10毫克和西替利嗪10毫克在缓解SAR症状方面的作用起效。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号